EASL is delighted to announce Digital NAFLD Summit 2021, taking place online 16–17 September 2021. The pandemic has disrupted medical associations, but we’re in full force holding engaging, interactive online events keeping the hepatology community both connected and advancing. Let’s join force…
Multidisciplinary approaches to the health sciences are increasingly in demand – calling on multiple disciplines to tackle diseases from bench to bedside, from R&D through to patient care, often in multidisciplinary tumour boards or centres of excellence. Opportunities to publish this cross-cutti…
EASL is pleased to announce the second round of abstract submissions for ILC 2021. We are calling for companies, scientists, researchers, and investigators to submit regular and high-profile, late-breaker abstracts, 10–27 April 2021. Take advantage of the next round of abstract submissions In li…
About EASL and the A-TANGO Consortium The A-TANGO Consortium, a five-year project, consists of 14 institutions across eight countries in Europe. It aims to perform Phase II clinical studies of an innovative therapeutic strategy that targets inflammation and improves liver regeneration – a novel c…
There is only one week left to take advantage of ILC 2021 early fees! The deadline is Monday, 22 March 23:59 CET. Don’t wait for the last minute to save up to EUR 450. Browse the categories to find out what your early fees are, whether you count as a delegate, Young Investigator, nurse, patient, or…
EASL’s ILC 2021 will be the 56th iteration of a flagship annual congress – a firmly rooted tradition that is set to be a sparkling, four-day virtual event taking place 23–26 June 2021. Over half a century has passed since the first EASL meeting took place in 1966 in person, with only a cluster of…
Are you deeply engaged in hepatology and science and ready to get involved in EASL’s governance? EASL is now looking to fill the following positions: EASL Vice–Secretary Three Educational Committee Members Three Policy and Public Health Committee Members Three Young Investigators Task Fo…
EASL honours Rare Disease Day, taking place this Sunday, 28 February. An estimated 300 million people globally are affected by rare diseases – diseases of which 6,000 have been identified. The day serves to raise awareness among the general public and decision-makers about rare diseases and their…
In the wake of the COVID-19 pandemic, several liver associations recommended certain changes in hepatitis clinical care to mitigate transmission risks for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), the causative agent of COVID-19. A follow-up survey was conducted and published. …
On International Day of Women and Girls in Science, 11 February, EASL honours the many women making waves in our field of hepatology. As highlighted by the UN, both science and gender equality are vital for us to achieve the internationally agreed development goals enshrined in Transforming our W…
